INGNInogen, Inc.

INGN Stock Price, Valuation & Chart | Inogen, Inc.

Compare

$5.390+0.06 (+1.13%)

At close · 02 Sept 2026, 08:00 pm

Sector: Healthcare Industry: Medical - Devices INGN intrinsic value INGN calculated fair value vs price

Overview Financials Dividends Ratios

INGN Historical price chart

INGN Key Stats

Fair Value

Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock

Market Capitalization145.93M

PE Ratio-5.92

EPS-0.91

Trading Volume249.42K

Today's High/Low5.47/5.34

Dividend Yield0.00

52 Week High/Low9.13/5.32

Shares Outstanding27.07M

INGN Financial Statement

INGN Analyst ratings

INGN Analysis & performance metrics

INGN Company profile

Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party…

Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen…

INGN Management team

Name

Position

Kevin R. M. SmithCEO

President, Chief Executive Officer & Director

Paul Andreassi

Senior Vice President of Quality & Regulatory Affairs

Grgoire Ramade

Executive Vice President & Chief Commercial Officer

Krishna Jhaveri

Chief Medical Officer

Jennifer Yi Boyer

Executive Vice President & Chief Human Resources Officer

Kevin P. Smith

General Counsel, Secretary & Executive Vice President of Business Development

Philip Corrin

Senior Vice President of Operations & Supply Chain

Adrien Mithalal

Senior Vice President of Research & Development

Name

Position

Kevin R. M. SmithCEO

President, Chief Executive Officer & Director

Paul Andreassi

Senior Vice President of Quality & Regulatory Affairs

Grgoire Ramade

Executive Vice President & Chief Commercial Officer

Krishna Jhaveri

Chief Medical Officer

Jennifer Yi Boyer

Executive Vice President & Chief Human Resources Officer

Kevin P. Smith

General Counsel, Secretary & Executive Vice President of Business Development

Philip Corrin

Senior Vice President of Operations & Supply Chain

Adrien Mithalal

Senior Vice President of Research & Development

Management Team

Kevin R. M. SmithCEO

President, Chief Executive Officer & Director

Paul Andreassi

Senior Vice President of Quality & Regulatory Affairs

Grgoire Ramade

Executive Vice President & Chief Commercial Officer

Krishna Jhaveri

Chief Medical Officer

Jennifer Yi Boyer

Executive Vice President & Chief Human Resources Officer

Kevin P. Smith

General Counsel, Secretary & Executive Vice President of Business Development

Philip Corrin

Senior Vice President of Operations & Supply Chain

Adrien Mithalal

Senior Vice President of Research & Development

Management

Kevin R. M. SmithCEO

President, Chief Executive Officer & Director

Paul Andreassi

Senior Vice President of Quality & Regulatory Affairs

Grgoire Ramade

Executive Vice President & Chief Commercial Officer

Krishna Jhaveri

Chief Medical Officer

Jennifer Yi Boyer

Executive Vice President & Chief Human Resources Officer

Kevin P. Smith

General Counsel, Secretary & Executive Vice President of Business Development

Philip Corrin

Senior Vice President of Operations & Supply Chain

Adrien Mithalal

Senior Vice President of Research & Development

Total 8 executives

INGN Frequently asked questions

What is Inogen, Inc. (INGN) Stock Price?

Current stock price of Inogen, Inc. (INGN) stock is $5.390. The stock price is +1.13% higher in the session. The intraday range can be seen from this page. Volume of Inogen, Inc. (INGN) stock is 249.42K.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the Inogen, Inc. (INGN) stock price going up or down today?

The stock price of Inogen, Inc. (INGN) can change with earnings, company news, and overall market sentiment. Inogen, Inc. operates in the Healthcare / Medical - Devices market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Inogen, Inc. stock expensive at its current price?

Whether Inogen, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for INGN on this page is -5.92. EPS on this page is -0.91. Compare those figures with peers and growth expectations before deciding if the current Inogen, Inc. price is justified.

How has the stock price of Inogen, Inc. (INGN) performed historically?

Historical performance for Inogen, Inc. (INGN) is shown on the price chart on this page. Review multi-period moves alongside volume to see how INGN reacted to past earnings and market events.

Should I buy Inogen, Inc. (INGN) stock, at this price?

Buying Inogen, Inc. (INGN) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.